POINT Biopharma Global In... (PNT)
12.50
0.02 (0.16%)
At close: Dec 26, 2023, 9:00 PM
0.16% (1D)
| Bid | n/a |
| Market Cap | 1.33B |
| Revenue (ttm) | 243.69M |
| Net Income (ttm) | 96.55M |
| EPS (ttm) | 1.1 |
| PE Ratio (ttm) | 11.363636363636363 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 3,290,875 |
| Avg. Volume (20D) | 3,849,591 |
| Open | 12.50 |
| Previous Close | 12.48 |
| Day's Range | 12.49 - 12.51 |
| 52-Week Range | 6.57 - 14.35 |
| Beta | -0.00 |
About PNT
POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate cancer; and PNT2003, a somatostatin-targeted radioligand, which is in Phase III trial for the treatment of ...
Industry Biotechnology
Sector Healthcare
IPO Date Jul 8, 2020
Employees 129
Stock Exchange NASDAQ
Ticker Symbol PNT
Website https://www.pointbiopharma.com